Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 27, 2026
Fred Hutch hematologists featured at 2026 Tandem Meetings
Researchers highlight findings on making stem cell transplants safer and more effective
Extramedullary disease shapes toxicity risk in BCMA CAR T therapy
From the Gauthier Group, Clinical Research Division
A tale of two T-cells: comparing liso-cel and axi-cel for treatment of refractory large B-cell lymphoma
From the Gauthier group, Clinical Research Division
From data to decisions: Enhancing CAR T-cell therapy with predictive modeling
From the Gauthier Group, Clinical Research Division
Automated, fast and accurate method to grade ICAHT, a CAR T-cell therapy side effect
From Dr. Emily Liang, Dr. Jordan Gauthier and colleagues, Clinical Research Division
Fred Hutch and UW hematology-oncology fellows win ASCO Young Investigator Awards
Winners represent broad range of research
Effective immunotherapy for relapsed or treatment-resistant leukemia
From Dr. Jordan Gauthier and colleagues, Clinical Research Division
Potential strategies for mitigating CD19 CAR T-cell associated toxicities
From the Gauthier Group, Clinical Research Division
Fred Hutch at ASH: Fauci fireside chat, latest on cell therapies, repairing immune function, COVID and clots — and more
The 62nd American Society of Hematology Annual Meeting and Exposition to be held virtually Dec. 5-8, 2020
If at first you don’t succeed: Testing outcomes of second CAR T-cell infusions
From the Turtle group and collaborators, Clinical Research Division
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?
First-of-its-kind study offers early indication of factors linked to increased odds of success for patients out of options